Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2025-02-18

FDA Approved: GABAPENTIN — Supplemental Application (American Health Packaging)

View source ↗

Summary

FDA approved a supplemental application for Gabapentin (generic) submitted by American Health Packaging, indicating a labeling change for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

SUPPL AP for GABAPENTIN (GABAPENTIN)